Sentence examples for trial barriers from inspiring English sources

In the trial, barriers not related to patients were encountered.

Several molecular and gene-expression profiling biomarkers have been proposed as markers of poor prognosis in stage II patients, but none has yet been validated in a large-scale prospective clinical trial (Barrier et al, 2007; Gangadhar and Schilsky, 2010; Ågesen et al, 2012).

This review will focus on the application of hESC-derived NK cells with currently used and novel therapeutics for clinical trials, barriers to translation, and future applications through genetic engineering approaches.

These items covered the following categories: "Time constraints" (3 items); "Difficulties including eligible patients" (7 items); "Limited human resources" (7 items); "Trial design barriers" (7 items); "Insufficient training of recruiting physicians" (2 items); "Individual barriers of recruiting physicians" (7 items); And "lack of access to treatment" (2 items).

There was little heterogeneity across the questions about "trial design barriers".

Surveys examining clinical trial enrollment barriers among African Americans have shown mixed results.

In each trial, the barriers were removed and the rats had to choose one arm to enter.

Although nearly half of respondents reported willingness to participate in an acupuncture clinical trial, significant barriers towards participation exist and differ among populations.

Also similar to our results, lack of incentives [ 3], trial design barriers [ 16, 3], limited human resources and insufficient training of recruiting physicians [ 3] were only reported by a few studies to represent major barriers.

Yet other factors may lead to exclusion from efficacy trials, such as a lack of trials occurring in racial/ethnic minority serving institutions, limited awareness of ongoing trials, work/family and insurance barriers, trial referral practices of PCPs, and the prevalence of co-morbid conditions [ 5- 7].

Reasons for this include ethical dilemmas in conducting such trials, communication barriers between specialties, and unclear standards for best care practices.